News & Analysis as of

DEA Dispensaries

Seyfarth Shaw LLP

The Week in Weed: August 2024 # 3

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have an update on the North Dakota ballot initiative. We see Delaware making progress on licensing....more

Seyfarth Shaw LLP

The Week in Weed: July 2024 # 3

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have some analysis of the comments on rescheduling cannabis, now that the comment period has ended. We...more

Seyfarth Shaw LLP

The Week in Weed: June 2024 #4

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, North Carolina considers a medical marijuana bill. Pennsylvania makes noises about legalizing adult-use....more

Troutman Pepper

Advising a Cannabis-Related Business: The Importance of Attorneys in Navigating the Marijuana Regulatory Framework and Licensing...

Troutman Pepper on

Introduction - The medicinal and recreational use and popularity of marijuana has continuously grown throughout the U.S. since Oregon became the first state to decriminalize marijuana in 1973. To date, thirty-eight states...more

Seyfarth Shaw LLP

The Week in Weed: May 2024 # 4

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we see the official publication of the DEA’s rescheduling rule. If you’d like to offer your thoughts to...more

Holland & Knight LLP

U.S. Drug Enforcement Administration Proposes Reclassification of Marijuana

Holland & Knight LLP on

The U.S. Drug Enforcement Administration (DEA) on May 16, 2024, issued a proposed rule to move marijuana from its current classification as a Schedule I drug to a Schedule III drug, thereby loosening federal DEA restrictions....more

Levenfeld Pearlstein, LLC

DOJ Recommends Rescheduling Cannabis – What This Could Mean for the Cannabis Industry

On April 30, 2024, the US Department of Justice recommended that cannabis be rescheduled as a Schedule III controlled substance, a classification shared by prescription drugs such as ketamine and Tylenol with codeine....more

Epstein Becker & Green

Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies?

A major update in cannabis law was announced by the Drug Enforcement Administration (DEA) and Attorney General (AG) this past Tuesday, April 30, 2024 regarding their intent to ease restrictions on cannabis. The DEA plans to...more

Akerman LLP

DEA Breaks Silence on Reclassification of Marijuana, Proposing Move to Schedule III

Akerman LLP on

After months of anticipation following the U.S. Department of Health and Human Services' recommendation to reschedule marijuana from a Schedule I to a Schedule III controlled substance, we finally have insight into the...more

Amundsen Davis LLC

A Major Step Towards Reform: The DEA Recommends Rescheduling Cannabis

Amundsen Davis LLC on

In a recent historic announcement, the U.S. Drug Enforcement Administration has determined that cannabis, which is currently categorized as a Schedule I drug under the Controlled Substances Act (CSA), should be rescheduled to...more

Seyfarth Shaw LLP

The Week in Weed: March 2024 # 3

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we note that New York Governor Hochul has had just about enough of the problems with cannabis licensing in...more

Troutman Pepper

Lawsuit Highlights the Complexity of Regulating the Intrastate Use of Marijuana

Troutman Pepper on

One of the most interesting aspects of marijuana law and policy in the U.S. is its tendency to strike at our most foundational democratic principles. In 2005, the U.S. Supreme Court held, in Gonzales v. Raich, that Congress...more

Seyfarth Shaw LLP

The Week in Weed: February 2024

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. We see some movement on setting up a retail market in Virginia. Senate Democrats would like to see less re-scheduling...more

Seyfarth Shaw LLP

The Week in Weed: January 2024 # 2

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we note that HHS released the full text of its report on cannabis rescheduling. ...more

Husch Blackwell LLP

Wisconsin Medical Marijuana…Maybe

Husch Blackwell LLP on

I split my time between Los Angeles and Milwaukee these days (I’m eligible to practice law in Wisconsin), and I often find myself working from my firm’s Milwaukee office depending on the month. Wisconsin is an incredibly...more

Troutman Pepper

HHS Proposes Rescheduling Cannabis to Schedule III – What It Means for the Industry

Troutman Pepper on

It has been widely reported and confirmed publicly that, on August 29, the U.S. Department of Health and Human Services (HHS) sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be moved from...more

Burns & Levinson LLP

HHS Recommends DEA to Reclassify Marijuana as a Schedule III Substance – Which Could Significantly Benefit the Cannabis Industry

Burns & Levinson LLP on

On August 30, 2023, HHS recommended that marijuana be reclassified by the Drug Enforcement Agency (DEA) as a Schedule III substance under the Controlled Substances Act (CSA), according to Bloomberg. This could have an...more

Kelley Drye & Warren LLP

CBD and Hemp Legal and Regulatory Roundup – December 2021

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD - CBD products company sued for failing to provide accessible website - Rasheta Bunting filed the lawsuit on behalf of all...more

Seyfarth Shaw LLP

The Week in Weed: May 2020 #3

Seyfarth Shaw LLP on

The big news this week is that cannabis banking is included in the latest federal relief bill. SBA funds, however, are not. There’s also lots of state news. We’ve got an update on the latest Montana legalization...more

Seyfarth Shaw LLP

The Week in Weed: May 2020 #2

Seyfarth Shaw LLP on

We’re starting out this week with state news.  We’ll visit Montana, Illinois, California and Massachusetts.  On the federal level, there’s some support for cannabis to be part of the next stimulus bill.  And there’s an issue...more

Cozen O'Connor

Controlled Substances, CBD and COVID-19

Cozen O'Connor on

While the country wrestles with the coronavirus pandemic, the federal government and many state governments recently made key determinations that could shape the future of the cannabis, hemp, and CBD industries for years to...more

Seyfarth Shaw LLP

The Week in Weed: April 2020

Seyfarth Shaw LLP on

Of course, what’s happening in the cannabis world is what’s happening everywhere else: the coronavirus.  We’ve got lots to report on how the pandemic is affecting marijuana, but let’s start with other news first. ...more

Seyfarth Shaw LLP

The Week in Weed: March 2020 #4

Seyfarth Shaw LLP on

Let’s start off with the DEA.  On Monday, they released a proposed rule to expand marijuana research.  For the first time, more than one institution would be permitted to register with the agency and grow cannabis.  The...more

Seyfarth Shaw LLP

The Week in Weed: March 2020

Seyfarth Shaw LLP on

To cap or not to cap, that was the question facing the state of Florida this week.  Lawmakers wrestled with the issue of capping THC content in medical marijuana for those patients under the age of 21.  The Senate Rules...more

Cozen O'Connor

The Legality of Cannabidiol and Concerns Regarding False Advertising

Cozen O'Connor on

The legality of marijuana (also known as cannabis) has been a popular topic in recent years with thirty states and the District of Columbia having laws that legalize marijuana in some form. However, under federal law,...more

28 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide